English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [351]
News [1713]
Articles [83]
Editorials [3]
Conferences [74]
elearning [15]
STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to...
Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to-intermediate HCC ( Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Jun 2026
ASCO 2026: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2026: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
1 Jun 2026
Olaparib plus pembrolizumab improves response but not PFS in BRCA-mutant...
Dr Vincent Chung - City of Hope, Duarte, USA
Olaparib plus pembrolizumab improves response but not PFS in BRCA-mutant pancreatic cancer ( Dr Vincent Chung - City of Hope, Duarte, USA )
1 Jun 2026
Yoga improves mood, fatigue, and insomnia in cancer survivors following...
Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA
Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment ( Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA )
31 May 2026
Daraxonrasib plus chemotherapy shows promising first-line activity in RAS...
Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA
Daraxonrasib plus chemotherapy shows promising first-line activity in RAS-mutant metastatic pancreatic cancer ( Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA )
27 Apr 2026
Tumour-selective oncolytic adenovirus LOAd703 with chemo shows immune...
Dr Angelica Loskog - Uppsala University, Uppsala, Sweden
Tumour-selective oncolytic adenovirus LOAd703 with chemo shows immune activation and promising responses in pancreatic cancer ( Dr Angelica Loskog -  Uppsala University, Uppsala, Sweden )
24 Apr 2026
Oncolytic adenovirus VCN-01 plus chemo shows promising survival benefit in...
Dr Manuel Hidalgo - NYU Langone Health, New York, USA
Oncolytic adenovirus VCN-01 plus chemo shows promising survival benefit in metastatic pancreatic cancer ( Dr Manuel Hidalgo - NYU Langone Health, New York, USA )
24 Apr 2026
Using lived experience of pancreatic cancer to build faith-based support
Olayinka Sowemimo–Coker - Pancreatic cancer survivor and Founder of DChanger
Using lived experience of pancreatic cancer to build faith-based support ( Olayinka Sowemimo–Coker - Pancreatic cancer survivor and Founder of DChanger )
27 Jan 2026
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative...
Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma ( Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )
15 Jan 2026
Talquetamab plus teclistamab shows promise in true extramedullary multiple...
Dr Shahzad Raza - Cleveland Clinic, Cleveland, USA
Talquetamab plus teclistamab shows promise in true extramedullary multiple myeloma ( Dr Shahzad Raza - Cleveland Clinic, Cleveland, USA )
17 Dec 2025
Precision approaches to treating HPB cancers
Dr Milind Javle - The University of Texas MD Anderson Cancer Center Houston...
Precision approaches to treating HPB cancers ( Dr Milind Javle - The University of Texas MD Anderson Cancer Center Houston, Texas, EE. UU )
7 Nov 2025
MCED blood test demonstrates high specificity, strong predictive value, and...
Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection ( Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA )
19 Oct 2025
<12345…30>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top